| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 275,5 k € | -5.3% | 291,0 k € | +3.4% | 281,4 k € | +46.2% | 192,4 k € | +67.9% | 114,6 k € | +15.9% | 98,9 k € | -2.7% | 101,7 k € | +41.5% | 71,9 k € | -12.0% | 81,7 k € | -13.7% | 94,7 k € | +1.0% | 93,8 k € | -9.0% | 103,1 k € | +9.6% | 94,0 k € | +37.9% | 68,2 k € | +167.7% | 25,5 k € | -53.0% | 54,1 k € | -59.7% | 134,2 k € | -21.1% | 170,1 k € | +58.8% | 107,1 k € | -0.2% | 107,3 k € | |
| EBITDA | 189,1 k € | -8.1% | 205,8 k € | -4.0% | 214,4 k € | +74.9% | 122,6 k € | +169.8% | 45,4 k € | +17.6% | 38,6 k € | +3.4% | 37,4 k € | +262.4% | 10,3 k € | -52.7% | 21,8 k € | -41.3% | 37,2 k € | +6.4% | 35,0 k € | -19.1% | 43,2 k € | -11.3% | 48,7 k € | +106.5% | 23,6 k € | +229.9% | -18,2 k € | -152.1% | 34,9 k € | -73.7% | 132,5 k € | -21.3% | 168,3 k € | +59.6% | 105,5 k € | -0.2% | 105,7 k € | |
| Operating profit | 163,0 k € | -7.4% | 176,1 k € | -1.0% | 178,0 k € | +116.4% | 82,3 k € | +490.5% | 13,9 k € | +258.0% | 3,9 k € | +194.9% | -4,1 k € | +86.7% | -30,7 k € | -82.6% | -16,8 k € | -501.2% | 4,2 k € | +89.1% | 2,2 k € | -85.9% | 15,8 k € | -32.0% | 23,2 k € | +495.4% | -5,9 k € | +87.9% | -48,4 k € | -763.7% | -5,6 k € | -106.1% | 91,8 k € | -31.7% | 134,5 k € | +86.2% | 72,2 k € | +5.6% | 68,4 k € | |
| Profit/loss | 117,1 k € | -3.9% | 121,8 k € | -1.0% | 123,1 k € | +101.6% | 61,1 k € | +416.7% | 11,8 k € | +308.7% | 2,9 k € | +158.6% | -4,9 k € | +84.4% | -31,7 k € | -77.9% | -17,8 k € | -571.4% | 3,8 k € | +139.0% | 1,6 k € | -89.4% | 15,0 k € | -32.5% | 22,2 k € | +411.0% | -7,1 k € | +86.4% | -52,3 k € | -1738.3% | -2,8 k € | -103.2% | 88,8 k € | -30.0% | 126,9 k € | +98.1% | 64,1 k € | +11.6% | 57,4 k € | |
| Equity | 528,9 k € | -5.0% | 556,9 k € | +18.2% | 471,1 k € | +35.4% | 348,0 k € | +21.3% | 286,9 k € | +4.3% | 275,1 k € | +1.1% | 272,2 k € | -1.8% | 277,1 k € | -10.3% | 308,9 k € | -5.5% | 326,7 k € | +1.2% | 322,9 k € | +0.5% | 321,3 k € | +4.9% | 306,3 k € | +7.8% | 284,2 k € | -2.4% | 291,3 k € | -15.2% | 343,6 k € | -0.8% | 346,4 k € | +7.1% | 323,6 k € | +6.2% | 304,7 k € | +6.1% | 287,1 k € | |
| Total assets | 697,2 k € | +12.2% | 621,6 k € | +22.4% | 507,7 k € | +31.5% | 386,2 k € | +13.7% | 339,7 k € | +12.8% | 301,0 k € | -7.2% | 324,5 k € | -5.1% | 341,8 k € | -8.8% | 374,5 k € | +1.3% | 369,8 k € | -3.1% | 381,7 k € | +1.7% | 375,3 k € | +3.0% | 364,5 k € | +1.6% | 358,9 k € | +6.2% | 337,8 k € | -12.4% | 385,6 k € | -25.7% | 519,2 k € | +13.2% | 458,6 k € | +9.4% | 419,3 k € | -4.6% | 439,5 k € | |
| Cash | 232,2 k € | +74.6% | 133,0 k € | -50.8% | 270,3 k € | +127.1% | 119,0 k € | +63.3% | 72,9 k € | +47.3% | 49,5 k € | +1.4% | 48,8 k € | +7.3% | 45,5 k € | -26.0% | 61,5 k € | +39.5% | 44,1 k € | +27.0% | 34,7 k € | -11.1% | 39,0 k € | -5.4% | 41,3 k € | +86.9% | 22,1 k € | +22.3% | 18,1 k € | +90.0% | 9,5 k € | -83.9% | 59,2 k € | +1329.3% | 4,1 k € | -53.6% | 8,9 k € | -64.0% | 24,8 k € | |
| Debts | 167,7 k € | +160.3% | 64,4 k € | +81.2% | 35,6 k € | -6.4% | 38,0 k € | -26.9% | 51,9 k € | +104.3% | 25,4 k € | -46.7% | 47,7 k € | -25.8% | 64,3 k € | -1.1% | 65,0 k € | +52.8% | 42,6 k € | -27.3% | 58,5 k € | +8.8% | 53,8 k € | -6.8% | 57,7 k € | -21.6% | 73,6 k € | +61.2% | 45,7 k € | +8.7% | 42,0 k € | -75.7% | 172,7 k € | +28.0% | 135,0 k € | +17.8% | 114,6 k € | -24.8% | 152,4 k € | |
| Staff | — | — | — | — | — | — | — | — | — | — | 1 | 1 | 1 | 1 | 1 | 0,4 | — | — | — | — | ||||||||||||||||||||
Private limited company · Sint-Genesius-Rode · incorporated on 10/01/1991
Private limited company profitable and well capitalised. Cash position rising (+74.6%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
CENTRE DE DIAGNOSTIC ET DE TRAITEMENT CARDIOLOGIQUE is a Private limited company incorporated in 1991. Its main activity is: Specialist medical practice activities. Its registered office is in Sint-Genesius-Rode.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette